Abstract
This editorial explores the complex landscape surrounding the use of medical cannabis for treating Multiple Sclerosis (MS) in Pakistan, a country with a significant prevalence of the condition but facing numerous challenges in cannabis utilization. Despite cannabis' historical therapeutic applications and emerging global recognition for its medical benefits, Pakistan's strict anti-cannabis laws, influenced by cultural and religious beliefs, significantly hinder its adoption. The editorial highlights the need for educational and regulatory frameworks to improve awareness and control the medical cannabis market, suggesting that such measures could enhance treatment options for MS patients and generate tax revenue, while addressing concerns about addiction and illegal trade.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
